소아 고혈압의 평가와 관리 방법; 한국 소아심장 전문의와 소아신장 전문의 설문 = Evaluating and managing hypertension in children: a survey of Korean cardiologists and nephrologists

다국어 초록 (Multilingual Abstract)

Purpose : Hypertension (HTN) is no longer an exclusively adult disease; the prevalence of pediatric HTN is increasing. To understand the evaluation and treatment of childhood HTN in Korea, we investigated, via a questionnaire, how hypertensive children are currently assessed and managed by pediatric cardiologists (CA) and nephrologists (NE).
Methods : We surveyed 82 pediatric CA and 77 NE, regarding how they manage hypertensive children in Korea.
Results : A total 75 replies were received to our questionnaire request (response rate: 47.15%). Routine blood pressure (BP) checks were more frequently performed by NE (CA: 5.7%, NE: 25%, P=0.03), but most respondents (86%) did not check BP routinely. Mercury sphygmomanometers were the most commonly used devices and ambulatory blood pressure monitoring was not frequently used. The goal BP in treated patients was set at the 95th percentile by 61% of respondents. NE used a lower BP goal in hypertensive children with renal disease (CA: 24%, NE: 64%, P=0.004) or DM (CA: 12.5%, NE: 50%, P= 0.003). Angiotensin converting enzyme (ACE) inhibitors were the most commonly used agents (mean: 59%); following ACE inhibitors, CA preferred diuretics for hypertensive children with renal disease or cardiovascular disease, and NE preferred calcium channel blockers, regardless of underlying disease. Self-monitoring was the most frequent method for BP monitoring at home.
Conclusion : In Korea, BP measurement is not yet a routine examination in treating hypertension. There are some differences in management strategies vis-à-vis hypertension, between pediatric cardiologists and nephrologists. For the appropriate management and prevention of secondary disease in long-term studies, standard guidelines and education are needed for pediatricians.

다국어 초록 (Multilingual Abstract)

Purpose : Hypertension (HTN) is no longer an exclusively adult disease; the prevalence of pediatric HTN is increasing. To understand the evaluation and treatment of childhood HTN in Korea, we investigated, via a questionnaire, how hypertensive children are currently assessed and managed by pediatric cardiologists (CA) and nephrologists (NE).
Methods : We surveyed 82 pediatric CA and 77 NE, regarding how they manage hypertensive children in Korea.
Results : A total 75 replies were received to our questionnaire request (response rate: 47.15%). Routine blood pressure (BP) checks were more frequently performed by NE (CA: 5.7%, NE: 25%, P=0.03), but most respondents (86%) did not check BP routinely. Mercury sphygmomanometers were the most commonly used devices and ambulatory blood pressure monitoring was not frequently used. The goal BP in treated patients was set at the 95th percentile by 61% of respondents. NE used a lower BP goal in hypertensive children with renal disease (CA: 24%, NE: 64%, P=0.004) or DM (CA: 12.5%, NE: 50%, P= 0.003). Angiotensin converting enzyme (ACE) inhibitors were the most commonly used agents (mean: 59%); following ACE inhibitors, CA preferred diuretics for hypertensive children with renal disease or cardiovascular disease, and NE preferred calcium channel blockers, regardless of underlying disease. Self-monitoring was the most frequent method for BP monitoring at home.
Conclusion : In Korea, BP measurement is not yet a routine examination in treating hypertension. There are some differences in management strategies vis-à-vis hypertension, between pediatric cardiologists and nephrologists. For the appropriate management and prevention of secondary disease in long-term studies, standard guidelines and education are needed for pediatricians.

참고문헌 (Reference)

1 Bald M, "[Home blood pressure self-measurement in children and adolescents with renal replacement therapy]" 213 : 21-25, 2001

2 National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents, "Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program" 98 : 649-658, 1996

3 Gashti CN, "The role of calcium antagonists in chronic kidney disease" 13 : 155-161, 2004

4 Falkner B, "The relationship of body mass index and blood pressure in primary care pediatric patients" 148 : 195-200, 2006

5 National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents, "The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents" 114 : 555-576, 2004

6 National Heart, Lung, and Blood Institute, Bethesda, Maryland, "Report of the second task force on blood pressure control in children-1987. Task force on blood pressure control in children" 79 : 1-25, 1987

7 Flynn JT, "Pharmacologic treatment of hypertension in children and adolescents" 149 : 746-754, 2006

8 Schiel R, "Overweight, obesity and elevated blood pressure in children and adolescents" 11 : 97-101, 2006

9 Sorof JM, "Overweight, ethnicity, and the prevalence of hypertension in school-aged children" 113 : 475-482, 2004

10 Ribeiro J, "Overweight and obesity in children and adolescents: relationship with blood pressure, and physical activity" 30 : 203-213, 2003

11 Kaufmann MA, "Oscillometric blood pressure measurements by different devices are not interchangeable" 82 : 377-381, 1996

12 Bald M, "Measurement of blood pressure at home: survey among pediatric nephrologists" 16 : 1058-1062, 2001

13 ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, "Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)" 288 : 2981-2997, 2002

14 Lande MB, "Lande MB, Flynn JT. Treatment of hypertension in children and adolescents. Pediatr Nephrol [Epub ahead of print]"

15 Monzavi R, "Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention" 117 : e1111-e1118, 2006

16 Nilsson AB, "IGF-I treatment attenuates renal abnormalities induced by neonatal ACE inhibition" 279 : r1050-r1060, 2000

17 Woroniecki RP, "How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists" 20 : 791-797, 2005

18 Gompels C, "Home blood pressure monitoring in diabetes" 67 : 636-639, 1992

19 Nilsson AB, "Growth hormone aggravates renal abnormalities induced by neonatal enalapril treatment" 18 : 878-886, 2003

20 Chen AK, "Effect of a short-term diet and exercise intervention on metabolic syndrome in overweight children" 55 : 871-878, 2006

21 O'Brien E, "Demise of the mercury sphygmomanometer and the dawning of a new era in blood pressure measurement" 8 : 19-21, 2003

22 McNiece KL, "Ambulatory blood pressure monitoring: what a pediatrician should know" 19 : 178-182, 2007

23 Bagga A, "Ali U. Evaluation and management of hypertension" 44 : 103-121, 2007

24 "After the diagnosis: adherence and persistence with hypertension therapy" 11 : s395-s399, 2005

25 Varda NM, "A diagnostic approach for the child with hypertension" 20 : 499-506, 2005